Background: NLG207 (formerly CRLX101) is an investigational nanoparticle-drug conjugate (NDC) composed of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase-1 inhibitor. NDCs enhance drug delivery to tumors where gradua...查看全文
一年交易一次2018-10-19 08:05
$NewLink Genetics Corporation (NLNK)$ NewLink Genetics to Host Its Third Quarter 2018 Financial Results Conference Call on November 1, 2018 网页链接查看全文
WitnessBio2018-08-01 09:00
$NewLink Genetics Corporation (NLNK)$ Hammered by a series of setbacks, NewLink axes staff (again) and circles its wagons around troubled IDO program.
Endpoints查看全文
$Newlink(NLNK)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-01-27 AccNo: 0000215457-16-003563 Size: 13 KB 网页链接
$Newlink(NLNK)$ 8-K - Current report Filed: 2016-01-22 AccNo: 0001126234-16-000216 Size: 62 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Newlink(NLNK)$ 8-K - Current report Filed: 2016-01-07 AccNo: 0001126234-16-000214 Size: 776 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arra...
$Newlink(NLNK)$ 内部交易: 2016-01-05,总裁, Chief Medical Offic,Vahanian Nicholas N. ,卖出,3011普通股, $35.06
$Newlink(NLNK)$ 内部交易: 2016-01-06,董事会主席 and CEO,Link Charles J. Jr. ,卖出,25000普通股, $32.53
$Newlink(NLNK)$ 内部交易: 2016-01-05,董事会主席 and CEO,Link Charles J. Jr. ,卖出,5001普通股, $35.06
$Newlink(NLNK)$ 内部交易: 2016-01-05,VP of Business Development,Wiley Brian ,卖出,1295普通股, $34.99
$Newlink(NLNK)$ 内部交易: 2016-01-05,Principal Accounting Officer,Langren Carl W. ,卖出,1095普通股, $34.97
$Newlink(NLNK)$ 内部交易: 2016-01-05,EVP, CFO,HENNEMAN JOHN B III ,卖出,175普通股, $35.74
$Newlink(NLNK)$ 8-K - Current report Filed: 2015-12-15 AccNo: 0001126234-15-000201 Size: 97 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接